Literature DB >> 27866240

Extranodal lymphomas of abdomen and pelvis: imaging findings and differential diagnosis.

Sandeep S Hedgire1, Shreyas Kudrimoti2, Irai S Oliveira2, Nishad Nadkarni3, Shaunagh McDermott2, Peter F Hahn2, Mari Mino-Kenudson4, Mukesh G Harisinghani2.   

Abstract

A wide spectrum of extranodal lymphomas in the abdomen and pelvis is commonly encountered by imaging. Diagnosing these lesions generally requires a multimodality approach. This review highlights imaging appearances of extranodal lymphomas in the abdomen and pelvis with emphasis on computed tomography, magnetic resonance imaging, and positron emission tomography-computed tomography along with the relevant differential diagnosis.

Entities:  

Keywords:  Abdomino-pelvic; Computed tomography; Extranodal; Lymphoma; Magnetic resonance; Positron emission tomography

Mesh:

Year:  2017        PMID: 27866240     DOI: 10.1007/s00261-016-0964-8

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  5 in total

Review 1.  [Extranodal abdominal lymphomas].

Authors:  T F Weber; S Dietrich; J Nattenmüller
Journal:  Radiologe       Date:  2018-01       Impact factor: 0.635

Review 2.  Complications of lymphoma in the abdomen and pelvis: clinical and imaging review.

Authors:  Mihran Khdhir; Tamara El Annan; Mohammad Ali El Amine; Muhammed Shareef
Journal:  Abdom Radiol (NY)       Date:  2022-06-12

3.  Unicentric or Multicentric Castleman disease? A case report of a pelvic intraperitoneal mass in a middle aged woman.

Authors:  Antonella Smedile; Francesca Capuano; Sara Fraticelli; Marco Lucioni; Alfredo La Fianza
Journal:  J Radiol Case Rep       Date:  2019-03-31

4.  Renal Lymphoma Mimicking a Retroperitoneal Hematoma.

Authors:  Ana Primitivo; Pedro M Sousa; Ana F Ferreira
Journal:  Cureus       Date:  2021-05-18

Review 5.  Primary hepatopancreatobiliary lymphoma: Pathogenesis, diagnosis, and management.

Authors:  Qianwen Wang; Kangze Wu; Xuzhao Zhang; Yang Liu; Zhouyi Sun; Shumei Wei; Bo Zhang
Journal:  Front Oncol       Date:  2022-08-30       Impact factor: 5.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.